Journal Article

HPLC Determination of Cocaine and Benzoylecgonine in Plasma and Urine from Drug Abusers

P. Fernández, N. Lafuente, A.M. Bermejo, M. López-Rivadulla and A. Cruz

in Journal of Analytical Toxicology

Volume 20, issue 4, pages 224-228
Published in print July 1996 | ISSN: 0146-4760
e-ISSN: 1945-2403 | DOI: http://dx.doi.org/10.1093/jat/20.4.224
HPLC Determination of Cocaine and Benzoylecgonine in Plasma and Urine from Drug Abusers

More Like This

Show all results sharing these subjects:

  • Medical Toxicology
  • Toxicology (Non-medical)

GO

Show Summary Details

Preview

Reversed-phase high-performance liquid chromatography (HPLC) was used for the determination of cocaine and its metabolite, benzoylecgonine (BZE), in plasma and urine. Following a solid-liquid extraction with Bond-Elut Certify cartridges and using methaqualone as reference compound, chromatography was performed with a Lichrospher RP 18 (125 × 4-ram i.d.) reversed-phase column, ultraviolet (UV) detection at 235 nm, and methanol (pH 7)-phosphate buffer (70:30, v/v) as mobile phase. Linearity was obtained from 0.1 to 20 pg/mL with a good correlation coefficient. Recoveries ranged from 76.9 to 96.5%, and coefficients of variation were always less than 5.0%. Urine samples from live, cocaine-intoxicated patients contained concentrations of 0.21–75.55 µg/mL BZE and less than 4.14 pg/mL cocaine, whereas postmortem urine analyses gave concentrations of 5.86–198.76 µpg/mL for BZE and 1.56–33.24 µg/mL for its parent compound. Finally, postmortem blood samples were all negative for cocaine and gave BZE concentrations of 0.040–0.53 µg/mL.

Journal Article.  0 words. 

Subjects: Medical Toxicology ; Toxicology (Non-medical)

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.